191 related articles for article (PubMed ID: 22574885)
21. The African Programme for Onchocerciasis Control (APOC).
Amazigo U
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():19-22. PubMed ID: 18718149
[TBL] [Abstract][Full Text] [Related]
22. Untreated villages and factors associated with the absence of Community-Directed Treatment with Ivermectin (CDTI) in DRC.
Makenga Bof JC; Ntumba Tshitoka F; Mpunga Mukendi D; Mansiangi Mankadi P; Ilunga-Ilunga F; Coppieters Y
J Infect Dev Ctries; 2018 Sep; 12(9):771-779. PubMed ID: 31999636
[TBL] [Abstract][Full Text] [Related]
23. African programme for Onchoceriasis control: ophthalmological findings in Bushenyi, Uganda.
Babalola OE; Ogbuagu FK; Maegga BT; Braide EI; Magimbi C; Zoure H; Yameogo L; Seketeh A
West Afr J Med; 2011; 30(2):104-9. PubMed ID: 21984457
[TBL] [Abstract][Full Text] [Related]
24. The selection and validation of indicators for monitoring progress towards self-sustainment in community-directed, ivermectin-treatment programmes for onchocerciasis control in Uganda.
Katabarwa MN; Mutabazi D
Ann Trop Med Parasitol; 1998 Dec; 92(8):859-68. PubMed ID: 10396346
[TBL] [Abstract][Full Text] [Related]
25. Involvement and performance of women in community-directed treatment with ivermectin for onchocerciasis control in Rukungiri District, Uganda.
Katabarwa MN; Habomugisha P; Agunyo S
Health Soc Care Community; 2002 Sep; 10(5):382-93. PubMed ID: 12390224
[TBL] [Abstract][Full Text] [Related]
26. Eliminating onchocerciasis as a public health problem: the beginning of the end.
Etya'alé D
Br J Ophthalmol; 2002 Aug; 86(8):844-6. PubMed ID: 12140199
[TBL] [Abstract][Full Text] [Related]
27. Partnership and promise: evolution of the African river-blindness campaigns.
Benton B; Bump J; Sékétéli A; Liese B
Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S5-14. PubMed ID: 12081251
[TBL] [Abstract][Full Text] [Related]
28. Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria.
Brieger WR; Okeibunor JC; Abiose AO; Wanji S; Elhassan E; Ndyomugyenyi R; Amazigo UV
Parasit Vectors; 2011 Jul; 4():152. PubMed ID: 21794139
[TBL] [Abstract][Full Text] [Related]
29. Contribution and performance of female Community-Directed Distributors in the treatment of onchocerciasis with Ivermectin in Sub-Saharan Africa: a systematic review.
Vouking MZ; Tamo VC; Tadenfok CN
Pan Afr Med J; 2015; 20():188. PubMed ID: 26430485
[TBL] [Abstract][Full Text] [Related]
30. Monitoring ivermectin distributors involved in integrated health care services through community-directed interventions--a comparison of Cameroon and Uganda experiences over a period of three years (2004-2006).
Katabarwa M; Habomugisha P; Eyamba A; Agunyo S; Mentou C
Trop Med Int Health; 2010 Feb; 15(2):216-23. PubMed ID: 20002616
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation on implementation of the African programme for onchocerciasis control in Nigeria].
Xie Z; Nsofor I; Tolhurst R
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Jun; 44(3):403-6. PubMed ID: 22692311
[TBL] [Abstract][Full Text] [Related]
32. River blindness: NGOs agree Africa strategy in Geneva.
Essent Drugs Monit; 1993; (16):4. PubMed ID: 12319053
[TBL] [Abstract][Full Text] [Related]
33. Adverse reactions from community directed treatment with ivermectin (CDTI) for onchocerciasis and loiasis in Ondo State, Nigeria.
Otubanjo OA; Adeoye GO; Ibidapo CA; Akinsanya B; Okeke P; Atalabi T; Adejai ET; Braide E
Rev Biol Trop; 2008 Dec; 56(4):1635-43. PubMed ID: 19419072
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of onchocerciasis control in the Upper Denkyira East municipal in the forest area of Ghana: Responses of participants and distributors to the CDTI programme.
Agyemang ANO; Badu K; Baffour-Awuah S; Owusu-Dabo E; Biritwum NK; Garms R; Kruppa TF
Acta Trop; 2018 Sep; 185():357-362. PubMed ID: 29932933
[TBL] [Abstract][Full Text] [Related]
35. Factors affecting the attrition of community-directed distributors of ivermectin, in an onchocerciasis-control programme in the Imo and Abia states of south-eastern Nigeria.
Emukah EC; Enyinnaya U; Olaniran NS; Akpan EA; Hopkins DR; Miri ES; Amazigo U; Okoronkwo C; Stanley A; Rakers L; Richards FO; Katabarwa MN
Ann Trop Med Parasitol; 2008 Jan; 102(1):45-51. PubMed ID: 18186977
[TBL] [Abstract][Full Text] [Related]
36. The NGDO Co-ordination Group for Onchocerciasis Control.
Haddad D
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():35-8. PubMed ID: 18718153
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with coverage in community-directed treatment with ivermectin for onchocerciasis control in Oyo State, Nigeria.
Brieger WR; Otusanya SA; Oke GA; Oshiname FO; Adeniyi JD
Trop Med Int Health; 2002 Jan; 7(1):11-8. PubMed ID: 11851950
[TBL] [Abstract][Full Text] [Related]
38. The African Programme for Onchocerciasis Control: impact on onchocercal skin disease.
Ozoh GA; Murdoch ME; Bissek AC; Hagan M; Ogbuagu K; Shamad M; Braide EI; Boussinesq M; Noma MM; Murdoch IE; Sékétéli A; Amazigo UV
Trop Med Int Health; 2011 Jul; 16(7):875-83. PubMed ID: 21481109
[TBL] [Abstract][Full Text] [Related]
39. The challenge of establishing community-directed treatment with Mectizan in Uganda.
Okwero P
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S171-4. PubMed ID: 9861290
[TBL] [Abstract][Full Text] [Related]
40. Programmatic factors associated with the limited impact of Community-Directed Treatment with Ivermectin to control Onchocerciasis in three drainage basins of South West Cameroon.
Duamor CT; Datchoua-Poutcheu FR; Chounna Ndongmo WP; Yoah AT; Njukang E; Kah E; Maingeh MS; Kengne-Ouaffo JA; Tayong DB; Enyong PA; Wanji S
PLoS Negl Trop Dis; 2017 Nov; 11(11):e0005966. PubMed ID: 29155826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
